Uvax Bio, LLC
PrivateLast Round
VC Round
Mar 24, 2025
Total Funding Raised
$1.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Uvax Bio, LLC operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a VC Round in March 2025.
Uvax Bio, LLC is a biotechnology company that develops prophylactic vaccines for infectious diseases using its proprietary 1c-SApNP protein nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uvax Bio, LLC Comparables
Compare Uvax Bio, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| POP Biotechnologies, Inc. | 78% | |
| AstraZeneca | 77% | |
| Novavax Inc. | 74% |
For institutional investors. Book with your work email.
Uvax Bio, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2025 | ||||
| Grant | Oct 24, 2022 | ||||
| Series A | Sep 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Uvax Bio, LLC Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 102% MoM, reaching 1.9K.
- May 16, 2026
Monthly visitors grew 209% MoM, reaching 498.
For institutional investors. Book with your work email.
Uvax Bio, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Uvax Bio, LLC's valuation, stock price, and market status.
Is Uvax Bio, LLC a public or private company?
Uvax Bio, LLC is a private company.
What is the current stock price of Uvax Bio, LLC?
Uvax Bio, LLC is a private company, so its shares have no public market price. Caplight tracks Uvax Bio, LLC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Uvax Bio, LLC worth (valuation)?
Valuation information for Uvax Bio, LLC is not publicly available.
Can I buy Uvax Bio, LLC stock?
Uvax Bio, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Uvax Bio, LLC's last funding round?
Uvax Bio, LLC's most recent funding round was VC Round on March 24, 2025.
Who are the main investors in Uvax Bio, LLC?
Key investors in Uvax Bio, LLC include CEPI, NIH RADx.
Will Uvax Bio, LLC IPO soon?
No public IPO plans have been announced for Uvax Bio, LLC.
How can I track Uvax Bio, LLC secondary market activity?
Caplight tracks bids, offers, and trades in Uvax Bio, LLC's shares on secondary markets.